Chi-Ming Lam
Overview
    Explore the profile of Chi-Ming Lam including associated specialties, affiliations and a list of published articles.
          
  Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
  
  
  Snapshot
          Snapshot
              Articles
              13
            
            
              Citations
              1133
            
            
              Followers
              0
            
  
  Related Specialties
          Related Specialties
  Top 10 Co-Authors
          Top 10 Co-Authors
  Published In
          
        
        
        
  Affiliations
        Affiliations
    Soon will be listed here.
  
  Recent Articles
          1.
        
    
    Momtazmanesh S, Saghazadeh A, Becerra J, Aramesh K, Barba F, Bella F, et al.
  
  
    SN Compr Clin Med
    . 2021 May;
          3(8):1699-1703.
    
    PMID: 33997623
  
  
          Scientific collaboration has been a critical aspect of the development of all fields of science, particularly clinical medicine. It is well understood that myriads of benefits can be yielded by...
      
2.
        
    
    Hanaei S, Takian A, Majdzadeh R, Maboloc C, Grossmann I, Gomes O, et al.
  
  
    Disaster Med Public Health Prep
    . 2020 Oct;
          16(3):1172-1177.
    
    PMID: 33100253
  
  
          Since the beginning of 2020, the coronavirus disease (COVID-19) pandemic has dramatically influenced almost every aspect of human life. Activities requiring human gatherings have either been postponed, canceled, or held...
      
3.
        
    
    Lo O, Poon R, Lam C, Fan S
  
  
    World J Gastroenterol
    . 2004 Jun;
          10(12):1841-3.
    
    PMID: 15188521
  
  
          Inflammatory pseudotumor of the liver is a rare benign lesion that can mimic a malignant liver neoplasm. A case of inflammatory pseudotumor of the liver found in association with a...
      
4.
        
    
    Poon R, Ng K, Lam C, Ai V, Yuen J, Fan S
  
  
    Arch Surg
    . 2004 Mar;
          139(3):281-7.
    
    PMID: 15006885
  
  
          Hypothesis: Radiofrequency ablation is a safe and effective treatment for hepatocellular carcinomas 3.1 to 8.0 cm in diameter. Design: Case series with prospective data collection. Setting: Tertiary referral center. Patients:...
      
5.
        
    
    Poon R, Ng K, Lam C, Ai V, Yuen J, Fan S
  
  
    Ann Surg Oncol
    . 2004 Mar;
          11(3):281-9.
    
    PMID: 14993023
  
  
          Background: Limited data from recent studies suggested an increased risk of bleeding complications, needle-track seeding, and local recurrence after radiofrequency ablation (RFA) of subcapsular hepatocellular carcinoma (HCC). Methods: Between May...
      
6.
        
    
    Ng K, Poon R, Lo C, Liu C, Lam C, Ng I, et al.
  
  
    Arch Surg
    . 2004 Feb;
          139(2):193-200.
    
    PMID: 14769580
  
  
          Hypothesis: Preoperative fine-needle aspiration cytologic examination (FNAC) exerts a statistically significant adverse effect on long-term clinical outcome in patients with hepatocellular carcinoma (HCC). Design: Retrospective study. Setting: Tertiary referral center....
      
7.
        
    
    Liu C, Fan S, Lo C, Wong Y, Ng I, Lam C, et al.
  
  
    Ann Surg
    . 2004 Jan;
          239(2):194-201.
    
    PMID: 14745327
  
  
          Objective: The aim of this study was to determine whether abdominal drainage is beneficial after elective hepatic resection in patients with underlying chronic liver diseases. Summary Background Data: Traditionally, in...
      
8.
        
    
    Ng K, Lam C, Poon R, Ai V, Tso W, Fan S
  
  
    J Gastroenterol Hepatol
    . 2003 May;
          18(6):616-29.
    
    PMID: 12753142
  
  
          The management of primary and secondary malignant liver tumors poses a great challenge to clinicians. Although surgical resection is the gold-standard treatment, most patients have unresectable malignant liver tumors. Over...
      
9.
        
    
    Chan S, Liu C, Lo C, Lam C, Poon R, Yuen W, et al.
  
  
    Arch Surg
    . 2003 Mar;
          138(3):265-71.
    
    PMID: 12611572
  
  
          Background: Live donor liver transplantation (LDLT) mandates conversance in liver anatomy and major hepatectomy. Hepatocellular carcinoma is most reliably treated by hepatectomy. Hypothesis: The outcomes of major hepatectomy for hepatocellular...
      
10.
        
    
    Ng K, Lam C, Poon R, Fan S
  
  
    Asian J Surg
    . 2003 Jan;
          26(1):50-3; discussion 54.
    
    PMID: 12527497
  
  
          Recurrent hepatocellular carcinoma (HCC) deserves multidisciplinary treatment in addition to surgical resection. Radiofrequency ablation (RFA) is an evolving, localized, thermal ablative treatment for unresectable hepatocellular carcinoma (HCC). Though the preliminary...